GSA Capital Partners’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$800K Buy
2,247
+1,741
+344% +$560K 0.05% 735
2026
Q2
$244K Sell
506
-2,297
-82% -$610K 0.02% 1426
2026
Q1
$307K Buy
+2,803
New +$399K 0.02% 1238
2025
Q4
– Sell
-1,659
Closed -$325K – 2153
2025
Q3
$325K Sell
1,659
-960
-37% -$158K 0.03% 1154
2025
Q2
$237K Buy
+2,619
New +$207K 0.02% 1406
2025
Q1
– Sell
-2,846
Closed -$377K – 2144
2024
Q4
$377K Buy
+2,846
New +$267K 0.03% 1082

Other funds holding ALAB

GSA Capital Partners's ALAB Position: Q3 2026 in Review

GSA Capital Partners increased its Astera Labs (ALAB) stake by 344% in Q3 2026, buying an estimated $560K and bringing the position to 2,247 shares worth $800K. The position accounts for 0.05% of the portfolio, ranked #735.

GSA Capital Partners first reported a position in ALAB in Q4 2024 and has held it in 6 quarters since. 1,001 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.

  • GSA Capital Partners held 2,247 shares of Astera Labs worth $800K as of Q3 2026.
  • GSA Capital Partners bought 1,741 Astera Labs shares in Q3 2026, an estimated $560K.
  • Astera Labs made up 0.05% of GSA Capital Partners's portfolio in Q3 2026, its #735 holding.
  • GSA Capital Partners first reported a position in Astera Labs in Q4 2024 and has held it in 6 quarters since.
  • 1,001 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.

Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.